CVE:RLV - Relevium Technologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$0.12 0.00 (0.00 %)
(As of 08/19/2018 03:15 PM ET)
Previous CloseC$0.12
Today's RangeC$0.12 - C$0.12
52-Week RangeC$0.09 - C$0.35
Volume165,410 shs
Average Volume775,681 shs
Market CapitalizationC$13.93 million
P/E RatioN/A
Dividend YieldN/A
Relevium Technologies Inc. engages in the identification, evaluation, and acquisition of assets or businesses in the health and wellness markets. It primarily focuses in the areas of e-commerce and wellness services, as well as on nutraceuticals, sports nutrition, and nutri-cosmeceutical products. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. The company was incorporated in 2012 and is headquartered in Montreal, Canada. Relevium Technologies Inc. is a subsidiary of iTech Medical, Inc.

Receive RLV News and Ratings via Email

Sign-up to receive the latest news and ratings for RLV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange CVE
Industry Medical Instruments & Supplies


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-11.08%
Return on Equity-22.67%
Return on Assets-7.21%


Outstanding Shares104,806,000
Market CapC$13.93 million

Relevium Technologies (CVE:RLV) Frequently Asked Questions

What is Relevium Technologies' stock symbol?

Relevium Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RLV."

Who are some of Relevium Technologies' key competitors?

Who are Relevium Technologies' key executives?

Relevium Technologies' management team includes the folowing people:
  • Mr. Aurelio Useche C.M.A., M.B.A., Pres, CEO & Director (Age 50)
  • Mr. Edward Ierfino B. Comm., Mang. of Investor Relations (Age 50)
  • Mr. Wayne D. Cockburn, Consultant (Age 61)
  • Mr. Faycal Salek, Chief Financial Officer
  • Mr. Abis Hussain, Sr. Marketing Officer

Has Relevium Technologies been receiving favorable news coverage?

Press coverage about RLV stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Relevium Technologies earned a daily sentiment score of 0.11 on Accern's scale. They also assigned media coverage about the company an impact score of 46.87 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term. View Recent Headlines for Relevium Technologies.

How do I buy shares of Relevium Technologies?

Shares of RLV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Relevium Technologies' stock price today?

One share of RLV stock can currently be purchased for approximately C$0.12.

How big of a company is Relevium Technologies?

Relevium Technologies has a market capitalization of C$13.93 million.

How can I contact Relevium Technologies?

Relevium Technologies' mailing address is 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada. The company can be reached via phone at +1-514-8248559.

MarketBeat Community Rating for Relevium Technologies (CVE RLV)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  41
MarketBeat's community ratings are surveys of what our community members think about Relevium Technologies and other stocks. Vote "Outperform" if you believe RLV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RLV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.